![]() ![]() The American Pain Foundation estimates that chronic pain costs approximately $100 billion per year in lost work time and health care expenses. According to the National Institutes of Health, 90 million people in the U.S. Patients can obtain more information about neurostimulation pain therapies at Pain is a serious and costly public health issue, and it remains largely under-treated and misunderstood. ![]() More than 35,000 patients in 35 countries have been implanted with St. Similar in function and appearance to cardiac pacemakers, these devices deliver mild electrical pulses to the spinal cord, interrupting or masking the pain signals' transmission to the brain. Neurostimulators like EonC are designed to provide SCS therapy to treat complex neuropathic pain of the trunk and limbs or pain from failed back surgeries. The new device complements Eon®, a high-capacity, rechargeable device, and Eon Mini™, the world's smallest, longest-lasting rechargeable neurostimulator. With the addition of EonC to its product portfolio, ANS now provides an even more comprehensive line of SCS devices to meet the needs of chronic pain patients. High power and high pulse frequencies which enable clinicians to adjust the therapy to accommodate individual patient needsĮonC is the only 16-contact, constant current, non-rechargeable system for SCS therapy.Constant current circuitry which automatically adjusts power output to deliver consistent therapy over time.Advanced programming capability which allows patients to adjust therapy strength in up to eight pain areas simultaneously and independently. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |